Knowledge can prevent anxiety. Withdrawal symptoms with SSRI's: Kennis inzetten tegen ongerusthied

Pieter Stolk, Jacqueline Hugtenburg, Toine Egberts

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Recently, the SSRI withdrawal syndrome has gained widespread attention in the popular and medical literature. Characteristics of the withdrawal syndrome can be diverse: disequilibrium and sleeping disorders or sensory, gastrointestinal, general somatic and flu-like symptoms are possible. Familiarity with the SSRI withdrawal syndrome can prevent unnecessary drug use, patient uneasiness and needless diagnostic procedures. The incidence of the syndrome in clinical practice has not yet been properly studied; however, there are indications that the risk is elevated in users of SSRI's with a short half-life. The mechanism behind the SSRI withdrawal syndrome is still unknown, though in some hypotheses serotonin or stress response play an important role. Determining whether a patient suffers from the SSRI withdrawal syndrome can be done on the basis of symptoms, or using the antidepressant as a diagnostic agent. When discontinuing an antidepressant the dose should always be tapered. Treating the symptoms of antidepressant withdrawal is, in general, not necessary; informing the patient about a possible withdrawal syndrome is. SSRI withdrawal syndrome should receive more attention in future standards and guidelines.

Translated title of the contributionKnowledge can prevent anxiety. Withdrawal symptoms with SSRI's
Original languageDutch
Pages (from-to)1607-1612
Number of pages6
JournalPharmaceutisch Weekblad
Volume138
Issue number46
Publication statusPublished - 14 Nov 2003

Cite this

@article{d8c9f25a2e0947698a1be9279b1c785c,
title = "Onttrekkingsverschinjnselen bij SSRI's: Kennis inzetten tegen ongerusthied",
abstract = "Recently, the SSRI withdrawal syndrome has gained widespread attention in the popular and medical literature. Characteristics of the withdrawal syndrome can be diverse: disequilibrium and sleeping disorders or sensory, gastrointestinal, general somatic and flu-like symptoms are possible. Familiarity with the SSRI withdrawal syndrome can prevent unnecessary drug use, patient uneasiness and needless diagnostic procedures. The incidence of the syndrome in clinical practice has not yet been properly studied; however, there are indications that the risk is elevated in users of SSRI's with a short half-life. The mechanism behind the SSRI withdrawal syndrome is still unknown, though in some hypotheses serotonin or stress response play an important role. Determining whether a patient suffers from the SSRI withdrawal syndrome can be done on the basis of symptoms, or using the antidepressant as a diagnostic agent. When discontinuing an antidepressant the dose should always be tapered. Treating the symptoms of antidepressant withdrawal is, in general, not necessary; informing the patient about a possible withdrawal syndrome is. SSRI withdrawal syndrome should receive more attention in future standards and guidelines.",
keywords = "Patient care, Serotonin uptake inhibitors, Substance withdrawal syndrome",
author = "Pieter Stolk and Jacqueline Hugtenburg and Toine Egberts",
year = "2003",
month = "11",
day = "14",
language = "Dutch",
volume = "138",
pages = "1607--1612",
journal = "Pharmaceutisch Weekblad",
issn = "0031-6911",
publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",
number = "46",

}

Onttrekkingsverschinjnselen bij SSRI's : Kennis inzetten tegen ongerusthied. / Stolk, Pieter; Hugtenburg, Jacqueline; Egberts, Toine.

In: Pharmaceutisch Weekblad, Vol. 138, No. 46, 14.11.2003, p. 1607-1612.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Onttrekkingsverschinjnselen bij SSRI's

T2 - Kennis inzetten tegen ongerusthied

AU - Stolk, Pieter

AU - Hugtenburg, Jacqueline

AU - Egberts, Toine

PY - 2003/11/14

Y1 - 2003/11/14

N2 - Recently, the SSRI withdrawal syndrome has gained widespread attention in the popular and medical literature. Characteristics of the withdrawal syndrome can be diverse: disequilibrium and sleeping disorders or sensory, gastrointestinal, general somatic and flu-like symptoms are possible. Familiarity with the SSRI withdrawal syndrome can prevent unnecessary drug use, patient uneasiness and needless diagnostic procedures. The incidence of the syndrome in clinical practice has not yet been properly studied; however, there are indications that the risk is elevated in users of SSRI's with a short half-life. The mechanism behind the SSRI withdrawal syndrome is still unknown, though in some hypotheses serotonin or stress response play an important role. Determining whether a patient suffers from the SSRI withdrawal syndrome can be done on the basis of symptoms, or using the antidepressant as a diagnostic agent. When discontinuing an antidepressant the dose should always be tapered. Treating the symptoms of antidepressant withdrawal is, in general, not necessary; informing the patient about a possible withdrawal syndrome is. SSRI withdrawal syndrome should receive more attention in future standards and guidelines.

AB - Recently, the SSRI withdrawal syndrome has gained widespread attention in the popular and medical literature. Characteristics of the withdrawal syndrome can be diverse: disequilibrium and sleeping disorders or sensory, gastrointestinal, general somatic and flu-like symptoms are possible. Familiarity with the SSRI withdrawal syndrome can prevent unnecessary drug use, patient uneasiness and needless diagnostic procedures. The incidence of the syndrome in clinical practice has not yet been properly studied; however, there are indications that the risk is elevated in users of SSRI's with a short half-life. The mechanism behind the SSRI withdrawal syndrome is still unknown, though in some hypotheses serotonin or stress response play an important role. Determining whether a patient suffers from the SSRI withdrawal syndrome can be done on the basis of symptoms, or using the antidepressant as a diagnostic agent. When discontinuing an antidepressant the dose should always be tapered. Treating the symptoms of antidepressant withdrawal is, in general, not necessary; informing the patient about a possible withdrawal syndrome is. SSRI withdrawal syndrome should receive more attention in future standards and guidelines.

KW - Patient care

KW - Serotonin uptake inhibitors

KW - Substance withdrawal syndrome

UR - http://www.scopus.com/inward/record.url?scp=0242680261&partnerID=8YFLogxK

M3 - Article

VL - 138

SP - 1607

EP - 1612

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

SN - 0031-6911

IS - 46

ER -